J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sunshine, A
Right arrow Articles by Goldenheim, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sunshine, A
Right arrow Articles by Goldenheim, P.

Articles

Analgesic efficacy of controlled-release oxycodone in postoperative pain

A Sunshine, NZ Olson, A Colon, J Rivera, RF Kaiko, RD Fitzmartin, RF Reder, and PD Goldenheim

The efficacy and safety of graded doses (10, 20, and 30 mg) of controlled-release (CR) oxycodone was compared with that of immediate-release (IR) oxycodone (15 mg), immediate-release oxycodone 10 mg in combination with acetaminophen 650 mg (APAP), and placebo in a single-dose, double-blind, randomized, parallel-group study. The participants, 182 inpatients experiencing moderate to severe pain after abdominal or gynecologic surgery, provided hourly ratings of pain intensity and relief for 12 hours after administration. All active treatments were significantly superior to placebo for many hourly measurements and for the sum of pain intensity differences (SPID) and total pain relief (TOTPAR). A dose response was found among the three levels of CR oxycodone for pain relief and peak pain intensity difference (PID), with the 20- and 30-mg doses being significantly better than the 10-mg dose. For all active treatments, peak PID and peak pain relief occurred approximately 2 to 4 hours after administration. The median time to onset of relief was 32 minutes for oxycodone plus APAP, 41 minutes for IR oxycodone, and 46 minutes for CR oxycodone 30 mg. Duration of pain relief showed that the 10-, 20-, and 30-mg doses of CR oxycodone had durations of action of 10 to 12 hours compared with IR oxycodone and oxycodone plus APAP (both approximately 7 hours). Typical adverse events, particularly somnolence, occurred in all active treatment groups. Treatment with CR oxycodone was safe and effective in this study, and its characteristics will be beneficial in the treatment of pain.


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
F. Chung, D. Tong, P. C. Miceli, J. Reiz, Z. Harsanyi, A. C. Darke, and L. W. Payne
Controlled-release codeine is equivalent to acetaminophen plus codeine for post-cholecystectomy analgesia: [La codeine a liberation controlee est equivalente a de l'acetaminophene plus de la codeine pour l'analgesie postcholecystectomie]
Can J Anesth, March 1, 2004; 51(3): 216 - 221.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
A. R. Gammaitoni, B. S. Galer, S. Bulloch, P. Lacouture, F. Caruso, T. Ma, and T. Schlagheck
Randomized, Double-Blind, Placebo-Controlled Comparison of the Analgesic Efficacy of Oxycodone 10 mg/Acetaminophen 325 mg versus Controlled-Release Oxycodone 20 mg in Postsurgical Pain
J. Clin. Pharmacol., March 1, 2003; 43(3): 296 - 304.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. S. Reuben and J. Sklar
Pain Management in Patients Who Undergo Outpatient Arthroscopic Surgery of the Knee
J. Bone Joint Surg. Am., December 1, 2000; 82(12): 1754 - 1754.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Clinical Pharmacology